Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02837952 · ClinicalTrials.gov registry record · Phase 3
A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain
A Phase 3 study of Pain, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 123
- Enrollment target
- 1
- Study location
NCT02837952 is a Phase 3 study of Pain that has completed, run by Pfizer. The registered enrollment target is 123 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02837952, a Phase 3 study of Pain, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 123 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to determine the overall analgesic efficacy and safety of a fixed-dose ibuprofen 250 mg / acetaminophen 500 mg formulation compared to placebo in subjects who are experiencing post operative pain following surgical extraction of 3 or more third molar teeth. A review of any reported adverse events will also be completed.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG FDC IBU/APAP 250 mg/500 mg
Study Locations (1)
Utah
- Pharmaceutical Research Associates, Inc. - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2016-08-31 |
| Est. Completion | 2017-02-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02837952
The ClinicalTrials.gov registry entry for NCT02837952 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (60% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02837952 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT02837952 about?
NCT02837952 is a clinical study titled "A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain". This study is being conducted to determine the overall analgesic efficacy and safety of a fixed-dose ibuprofen 250 mg / acetaminophen 500 mg formulation compared to placebo in subjects who are experiencing post operative pain following surgical extraction of 3 or more third molar teeth. A review of ...
What is the current status of trial NCT02837952?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 123 participants. The study started on 2016-08-31. Estimated completion is 2017-02-01.
What conditions does trial NCT02837952 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT02837952?
The interventions under investigation include: Placebo (DRUG), FDC IBU/APAP 250 mg/500 mg (DRUG).
Who is sponsoring clinical trial NCT02837952?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02837952 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.